| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |